[Experimentation of targeted cardio-neurovascular risk screening in pharmacies].

Objectives: Pharmacists' involvement in the screening of cardio-neurovascular diseases could enhance the prevention of cardio-neurovascular risk factors. This research-action assesses the pertinence of targeted screening for cardio-neurovascular risk in pharmacies.

Methods: This study was carried out within Lens-Hénin over the course of four months.

Fine-scale geographic variations of inflammatory bowel disease in France: correlation with socioeconomic and house equipment variables.

Background: In a previous study we found a north-south gradient for Crohn's disease (CD) incidence in France. The aim of the present study was to determine if socioeconomic factors may influence the geographic distribution of CD and ulcerative colitis (UC) in France.

Methods: Using the national health insurance databases, incidence rates of CD and UC were estimated for each of 341 metropolitan "job areas" in 2000-2002.

[Medical management of patients with stable coronary artery disease in France in 2004. Data from the Mutualité Sociale Agricole].

Aim: To describe the treatment of ambulatory patients with coronary artery disease, using information from the French farmers' insurance fund (Mutualité Sociale Agricole, MSA) database.

Population And Methods: Analysis of cardiovascular medications bought and reimbursed during the second quarter of 2004 for 16,694 patients affiliated with the MSA who were first diagnosed with coronary artery disease in 1998, 2001 or 2003.

Results: On average, 71% of patients received antiplatelet agents, 56% beta-blockers, 59% statins, and 36% ACE inhibitors.

Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data.

Background And Aim: A north-south gradient in inflammatory bowel disease (IBD) incidence has been found in Europe and the United States. Its existence is inferred from comparisons of registries that cover only small portions of territories. Several studies suggest that IBD incidence in the north has reached a plateau, whereas in the south it has risen sharply.